SpringerLink
Log in

Hepatic Coma

  • Chapter
Neurocritical Care

  • 254 Accesses

Abstract

Hepatic encephalopathy (HE) arises as a complication in fulminant hepatic failure (FHF) as well as in chronic liver failure. Initially it is characterized by minor mental and personality changes and discrete cognitive impairment. With progression there are prominent motor abnormalities, as well as increasing loss of consciousness until deep coma is present.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Suggested Reading

  • Bansky G, Meier PJ, Riederer E, Walser H, Ziegler WH, Schmid M (1989) Effects of the benzodiazepine-receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 97: 744–750

    PubMed  CAS  Google Scholar 

  • Basile AS, Skolnick P, Jones EA (1991) Benzodiazepine-receptor ligands and hepatic encephalopathy: electrophysiological and neurochemical studies. In: Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (eds) Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boca Raton, pp 131–136

    Google Scholar 

  • Bengtsson F (1991) Round-table discussion on brain monoamines• some personal reflections. In: Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (eds) Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boca Raton, pp 233–239

    Google Scholar 

  • Bergeron M, Pomier Layrargues G, Butterworth RF (1989a) Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Metab Brain Dis 4: 169–176

    Article  PubMed  CAS  Google Scholar 

  • Bergeron M, Reader TA, Pomier Layrargues G, Butterworth RF (1989b) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14: 853–859

    Article  PubMed  CAS  Google Scholar 

  • Bernau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6: 97–106

    Article  Google Scholar 

  • Brunner G (1991) Diagnose and Therapie des fulminanten Leberversagens. Internist (Berl) 32:256–261 950 K. Weißenborn et al.: Hepatic Coma

    Google Scholar 

  • Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37: 321–327

    Article  PubMed  CAS  Google Scholar 

  • Conn HO, Lieberthal MM (eds) (1979) The hepatic coma syndrome and lactulose. Williams and Wilkins, Baltimore

    Google Scholar 

  • Fischer JE, Baldessarini RJ (1971) False neurotransmitters and hepatic failure. Lancet 2: 75–80

    Article  PubMed  CAS  Google Scholar 

  • Grüngreiff K, Wolf G, Schmidt W, Franke D, Kleine FD (1991) High-affinity uptake of transmitter glutamate (GLU) in brain tissue with reference to hepatic encephalopathy (HE). Z Gastroenterol 29 [Suppl 2]: 95100

    Google Scholar 

  • Hindfelt B, Plum F, Duffy TE (1977) Effect of acute ammonia intoxication on cerebral metabolism in rats with portocaval shunts. J Clin Invest 59: 386–396

    Article  PubMed  CAS  Google Scholar 

  • Hütteroth TH, Meyer zum Büschenfelde KH (1988) Akutes Leberversagen. In: Schuster HP, Schölmerich P, Schönborn H, Baum PP (eds) Intensivmedizin. Innere Medizin, Neurologie, Reanimation, Intoxikationen. Thieme, Stuttgart, pp 281–292

    Google Scholar 

  • Manns MP (1991) Akutes Leberversagen: Definition, Ätiologie, klinisches Bild und Prognose. Z Gastroenterol [Verh] 26: 7–9

    CAS  Google Scholar 

  • Martin P, Pappas SC (1990) Fulminant hepatic failure. Dig Dis 8: 128–151

    Article  Google Scholar 

  • Morgan MY (1991) The treatment of chronic hepatic encephalopathy. Hepatogastroenterology 38: 377–387

    PubMed  CAS  Google Scholar 

  • O’Grady JG, Gimson AES, O’Brien CJ, Pucknell A, Hughes RD, Williams (1988) Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94: 1186–1192

    PubMed  Google Scholar 

  • Zieve L (1984) Role of synergism in the pathogenesis of hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F (eds) Hepatic encephalopathy in chronic liver failure. Plenum, New York, pp 15–23

    Chapter  Google Scholar 

  • Weissenborn K (1992) Recent developments in the pathophysiology and treatment of hepatic encephalopathy. In: Shields R (ed) Baillieres clinical gastroenterology: portal hypertension, vol 6 (3). Bailliere Tindall, London, pp 609–630

    Google Scholar 

Download references

Authors
  1. Karin Weissenborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis Marsano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Mae Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Klaus Kunze
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel F. Hanley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Ruprecht-Karls-University, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany

    Werner Hacke M.D. (Professor and Chairman) (Professor and Chairman)

  2. Department of Neurology, Johns Hopkins Hospital, 600 North Wall Street, 21205, Baltimore, MD, USA

    Daniel F. Hanley M.D. (Associate Professor, Director Neuroscience Critical) (Associate Professor, Director Neuroscience Critical)

  3. Department of Neurology, Humboldt University Berlin, Schumannstr. 20/21, 10117, Berlin, Germany

    Karl M. Einhäupl M.D. (Professor and Chairman, Charité) (Professor and Chairman, Charité)

  4. Department of Neurology, Medical Center, University of Virginia, Box 394, 22908, Charlottesville, VA, USA

    Thomas P. Bleck M.D. (Associate Professor) (Associate Professor)

  5. Department of Neurology, Washington University, Medical Center, 660 South Euclid Avenue, P.O. Box 8111, 63110, St. Louis, MO, USA

    Michael N. Diringer M.D. (Assistant Professor) (Assistant Professor)

  6. Department of Neurology, St. Elizabeth’s Hospital, 32 Fruit Street, 02114, Boston, MA, USA

    Allan H. Ropper M.D. (Professor of Neurology) (Professor of Neurology)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weissenborn, K., Marsano, L., Diehl, A.M., Kunze, K., Hanley, D.F. (1994). Hepatic Coma. In: Hacke, W., Hanley, D.F., Einhäupl, K.M., Bleck, T.P., Diringer, M.N., Ropper, A.H. (eds) Neurocritical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87602-8_89

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87602-8_89

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-87604-2

  • Online ISBN: 978-3-642-87602-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation